Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Another New Job Posted: Scientist Pharmaceutical Development
View:
Post by archeo753 on Oct 20, 2021 8:34pm

Another New Job Posted: Scientist Pharmaceutical Development

 

Position Summary

The incumbent will be responsible for supporting the development and scale-up of pharmaceutical process at third party suppliers. Preparing and reviewing technical reports to support the development activities.

Key Responsibilities

  • Keep appropriate records of any delegated duties
  • Support deviations, investigations and other quality issues are investigated and resolved.

External Customers

  • Suppliers related to manufacturing
  • Consultants 

Required Qualifications

  • Minimum of 4 to 5 years of relevant experience in a biotechnology/pharmaceutical/CRO environment/exposure to manufacturing environment, technical transfer activities.
  • Bachelor's degree in Chemistry or equivalent.
  • Good understanding of basic analytical chemistry.
  • Understanding of peptide chemistry (or organic chemistry or synthesis).
  • Data analysis, statistical, and trending proficiency.
  • Awareness of quality and regulatory requirements in the pharmaceutical industry.
  • Excellent communicator, and well-organized with superior presentation skills.
  • Knowledge of Word, Excel, Power Point and Outlook.

Personal Qualities for all Staff

  • Demonstrable communications skills (both oral and written)
  • Must be a detail-oriented individual with excellent organizational skills
  • Self-motivated with the ability to prioritize and meet multiple deadline
  • Proficiency with the English language
  • Ability to set goals and meet deadlines
  • Ability to prioritize
  • Ability to generate ideas and identify solutions
  • Ability to work both independently and in a team
  • Team spirit and excellent strategic and operational support to team members
  • Versatility and flexibility

Personal Qualities Specific to the Position

  • Results-oriented
  • Ability to negotiate and to influence others
  • Capable to establish priorities
  • Ability to multi-task with ease
  • Ability to learn quickly and demonstrate curiosity
  • Excellent attention to detail and quality in all matters
  • Fluency in written and oral expression
  • Discretion
  • Creativity
  • Rigor in tasks
  • Available for occasional business travel
Comment by Wino115 on Oct 21, 2021 9:48am
You can see the influence of the new HR person in how they describe the traits they desire.  I really hope they aren't doing all this hiring without having a high degree of certainty around future prospects to support this larger employee base.  Either that or they are cutting elsewhere.
Comment by SPCEO1 on Oct 21, 2021 10:06am
While we do not know the numbers, Paul did mention on a call recently that the US salesforce is now smaller. I would ot be surprised if they have 10 or more fewer sales people than they had previously. Now, that is also offset by additions to other marketing oriented staff but perhaps at a lower cost than a salesperson. I imagine they have a lot of turnover in their sales staff right  now ...more  
Comment by scarlet1967 on Oct 21, 2021 10:40am
  I think face to face marketing is now less relevant than digital marketing, I was a bit concerned when Paul mentioned in one of the CCs that in his mind post pandemic the sales will resume their growth due to personal visits by their sale force.  Fact is electronic marketing targeting both the doctors( they do have an influence on patients as their advice would effect ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities